SCHEMBL6515324

SCHEMBL6515324

CCOc1cccc(OCCCCc2cnc(-c3c(CC)cccc3CC)cc2OCC)c1

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.41
LMNA P02545 4/20 0.41
KDM4E B2RXH2 3/20 0.41
ALDH1A1 P00352 3/20 0.40
NPSR1 Q6W5P4 2/20 0.40
TSHR P16473 1/20 0.40
MAPK1 P28482 4/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C19 P33261 1/20 0.40
HTT P42858 1/20 0.39
MEN1 O00255 1/20 0.39
RECQL P46063 1/20 0.39
KMT2A Q03164 1/20 0.39
L3MBTL1 Q9Y468 4/20 0.38
DHFR P00374 3/20 0.36
RAB9A P51151 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6515014 0.89 MAPK1 (0.40) TSHRMAPK1CYP2D6L3MBTL1DHFR
SCHEMBL6516516 0.87 ALDH1A1 (0.41) ALDH1A1CYP1A2CYP2D6CYP2C19MEN1
SCHEMBL6522088 0.85 NPSR1 (0.36) MAPTLMNAKDM4EALDH1A1NPSR1
SCHEMBL6518505 0.84 C5AR1 (0.37) MAPTALDH1A1NPSR1L3MBTL1
SCHEMBL6523352 0.80 C5AR1 (0.38) L3MBTL1
SCHEMBL1329562 0.79 MEN1 (0.40) MAPTLMNAALDH1A1MAPK1CYP1A2
SCHEMBL1328624 0.78 ACACB (0.38) MAPTLMNAKDM4EALDH1A1NPSR1
SCHEMBL1328160 0.77 C5AR1 (0.41) MAPTALDH1A1NPSR1TSHRL3MBTL1
SCHEMBL6522038 0.77 C5AR1 (0.33) MAPTNPSR1L3MBTL1
SCHEMBL1327067 0.77 RXRA (0.35) MAPTLMNAKDM4EALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1565452-A2 3-SUBSTITUTED-6-ARYL PYRIDINES AS LIGANDS OF C5A RECEPTORS NEUROGEN CORPORATION (US) 2005-08-24 EP disclosed
WO-2004043925-A2 3-SUBSTITUTED-6-ARYL PYRIDINED AS LIGANDS OF C5A RECEPTORS NEUROGEN CORPORATION (US) 2004-05-27 WO disclosed